Research Article
[Retracted] Antileukemic Effects of Anti-miR-146a, Anti-miR-155, Anti-miR-181a, and Prednisolone on Childhood Acute Lymphoblastic Leukemia
Table 5
Annexin V results of SUP-B15 and NCI-BL 2171 cells.
| Treatment group | Live cell (%) | Necrotic cell (%) | Apoptotic cell (%) | Apoptotic fold change (to control) | SUP-B15 | NCI-BL 2171 | SUP-B15 | NCI-BL 2171 | SUP-B15 | NCI-BL 2171 | SUP-B15 | NCI-BL 2171 |
| Control | 83.30 | 98.70 | 16.40 | 0.90 | 0.30 | 0.40 | 1.00 | 1.00 | IC50 dose of prednisolone | 5.70 | 97.30 | 84.60 | 2.20 | 9.70 | 0.60 | 32.30 | 1.50 | Anti-miR-146a | 76.20 | 96.80 | 23.40 | 2.80 | 0.30 | 0.40 | 1.00 | 1.00 | Anti-miR-146a & IC50 dose of prednisolone | 9.00 | 98.40 | 86.00 | 1.40 | 4.90 | 0.20 | 16.30 | 0.50 | Anti-miR-155 | 80.70 | 94.00 | 15.80 | 5.40 | 3.60 | 0.60 | 12.00 | 1.50 | Anti-miR-155 & IC50 dose of prednisolone | 5.00 | 98.40 | 84.00 | 1.50 | 11.00 | 0.10 | 36.70 | 0.30 | Anti-miR-181a | 65.30 | 98.80 | 33.40 | 1.00 | 1.20 | 0.20 | 4.00 | 0.50 | Anti-miR-181a & IC50 dose of prednisolone | 4.10 | 98.70 | 81.20 | 1.20 | 14.70 | 0.00 | 49.00 | 0.00 | Anti-let-7e | 81.40 | 98.20 | 18.50 | 1.60 | 0.10 | 0.30 | 0.30 | 0.80 | Anti-let-7e & IC50 dose of prednisolone | 6.30 | 98.60 | 80.10 | 1.30 | 13.60 | 0.00 | 45.30 | 0.00 | Anti-miR-146a + anti-miR-155 + anti-miR-181a + anti-let-7e combination | 74.20 | 98.40 | 25.50 | 1.40 | 0.30 | 0.10 | 1.00 | 0.30 | Anti-miR-146a + anti-miR-155 + anti-miR-181a + anti-let-7e combination & IC50 dose of prednisolone | 5.60 | 98.50 | 68.10 | 1.40 | 26.20 | 0.10 | 87.30 | 0.30 |
|
|
Fisher’s exact test, <0.01, <0.001, and <0.0001. |